Patents by Inventor Amy F. Wilson

Amy F. Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of identifying melanin concentrating hormone receptor antagonists
    Patent number: 7393655
    Abstract: This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells comprising such vectors, antibodies directed to a human MCH1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human MCH1 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding human MCH1 receptors, transgenic, nonhuman animals which express DNA encoding a normal or mutant human MCH1 receptor, methods of isolating a human MCH1 receptor, methods of treating an abnormality that is linked to the activity of a human MCH1 receptor, as well as methods of determining binding of compounds to mammalian MCH1 receptors.
    Type: Grant
    Filed: April 15, 2004
    Date of Patent: July 1, 2008
    Assignee: H. Lundbeck A/S
    Inventors: John A. Salon, Thomas M. Laz, Raisa Nagorny, Amy F. Wilson
  • DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
    Publication number: 20040248173
    Abstract: This invention provides an isolated nucleic acid encoding a human MCH1 receptor, a purified human MCH1 receptor, vectors comprising isolated nucleic acid encoding a human MCH1 receptor, cells comprising such vectors, antibodies directed to a human MCH1 receptor, nucleic acid probes useful for detecting nucleic acid encoding human MCH1 receptors, antisense oligonucleotides complementary to unique sequences of nucleic acid encoding human MCH1 receptors, transgenic, nonhuman animals which express DNA encoding a normal or mutant human MCH1 receptor, methods of isolating a human MCH1 receptor, methods of treating an abnormality that is linked to the activity of a human MCH1 receptor, as well as methods of determining binding of compounds to mammalian MCH1 receptors.
    Type: Application
    Filed: April 15, 2004
    Publication date: December 9, 2004
    Applicant: Synaptic Pharmaceutical Corporation
    Inventors: John A. Salon, Thomas M. Laz, Raisa Nagorny, Amy F. Wilson